ng-nitroarginine methyl ester has been researched along with Nephrosclerosis in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (46.15) | 18.2507 |
2000's | 7 (53.85) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akimoto, K; Inaba, C; Koshikawa, S; Matsuoka, H; Nishikimi, T | 1 |
Bidani, AK; Griffin, KA; Loutzenhiser, R; Wang, X; Williamson, G | 1 |
Inada, H; Ishimitsu, T; Matsuoka, H; Minami, J; Ono, H | 1 |
Ishimitu, T; Matsuoka, H; Ono, H; Ono, Y; Saitoh, M | 1 |
Ishimitsu, T; Matsuoka, H; Ono, H; Ono, Y; Takahashi, T | 1 |
Frohlich, ED; Ono, H; Ono, Y | 2 |
Akuzawa, N; Hoshino, J; Kurashina, T; Nagai, R; Nakamura, T; Ono, Z; Saito, Y; Sakamoto, H; Sumino, H | 1 |
Aizawa, H; Akuzawa, N; Kurashina, T; Nagai, R; Nakamura, T; Ono, Z; Saito, Y; Sakamoto, H; Sumino, H | 1 |
Ardaillou, R; Casellas, D; Chatziantoniou, C; Dussaule, JC; Fouassier, L; Tharaux, PL | 1 |
Bruneval, P; Duong Van Huyen, JP; Heudes, D; Qiu, C; Roeckel, A; Roux, S | 1 |
Fujimori, T; Ishimitsu, T; Matsuoka, H; Ono, H; Ono, Y; Watanabe, S | 1 |
Frohlich, ED; Ono, H; Ono, Y; Zhou, X | 1 |
1 review(s) available for ng-nitroarginine methyl ester and Nephrosclerosis
Article | Year |
---|---|
Protective importance of the myogenic response in the renal circulation.
Topics: Animals; Disease Models, Animal; Female; Glomerular Filtration Rate; Homeostasis; Hypertension; Male; Nephrosclerosis; NG-Nitroarginine Methyl Ester; Primary Prevention; Proteinuria; Random Allocation; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Renal Circulation; Sensitivity and Specificity; Vascular Patency | 2009 |
12 other study(ies) available for ng-nitroarginine methyl ester and Nephrosclerosis
Article | Year |
---|---|
Fasudil, a Rho-kinase inhibitor, reverses L-NAME exacerbated severe nephrosclerosis in spontaneously hypertensive rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Collagen Type I; Collagen Type III; Drug Interactions; Enzyme Inhibitors; Hypertension, Renal; Intercellular Adhesion Molecule-1; Kidney; Male; NADPH Oxidases; Nephrosclerosis; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Plasminogen Activator Inhibitor 1; Protein Kinase Inhibitors; Rats; Rats, Inbred SHR; rho-Associated Kinases; rhoA GTP-Binding Protein; rhoB GTP-Binding Protein; RNA, Messenger; Superoxides; Transforming Growth Factor beta | 2008 |
Nipradilol prevents L-NAME-exacerbated nephrosclerosis with decreasing of caspase-3 expression in SHR.
Topics: Adrenergic beta-Antagonists; Animals; Apoptosis; Blood Pressure; Caspase 3; Caspases; Hypertension; Male; Nephrosclerosis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Organ Size; Proliferating Cell Nuclear Antigen; Propanolamines; Rats; Rats, Inbred SHR; Rats, Wistar | 2002 |
Imidapril improves L-NAME-exacerbated nephrosclerosis with TGF-beta 1 inhibition in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Aorta; Cardiomegaly; Caspase 3; Caspases; Enzyme Inhibitors; Hypertension, Renal; Imidazolidines; Kidney; Male; Nephrosclerosis; NG-Nitroarginine Methyl Ester; Organ Size; Rats; Rats, Inbred SHR; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |
Combination therapy with telmisartan and spironolactone alleviates L-NAME exacerbated nephrosclerosis with an increase in PPAR-gamma and decrease in TGF-beta(1).
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Disease Models, Animal; Drug Therapy, Combination; Hypertension, Malignant; Male; Mineralocorticoid Receptor Antagonists; Nephrosclerosis; NG-Nitroarginine Methyl Ester; PPAR gamma; Rats; Rats, Inbred SHR; RNA, Messenger; Spironolactone; Telmisartan; Transforming Growth Factor beta1 | 2007 |
ACE inhibition prevents and reverses L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Blood Pressure; Body Weight; Enzyme Inhibitors; Glomerular Filtration Rate; Heart; Heart Rate; Hemodynamics; Isoquinolines; Kidney; Kidney Glomerulus; Male; Nephrosclerosis; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Organ Size; Quinapril; Rats; Rats, Inbred SHR; Renal Circulation; Tetrahydroisoquinolines; Vascular Resistance | 1996 |
Hydrochlorothiazide exacerbates nitric oxide-blockade nephrosclerosis with glomerular hypertension in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Diuretics; Hemodynamics; Hydrochlorothiazide; Hypertension; Kidney; Male; Nephrosclerosis; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Proteinuria; Rats; Rats, Inbred SHR; Renal Circulation; Sodium Chloride Symporter Inhibitors; Vascular Resistance | 1996 |
Antihypertensive agents prevent nephrosclerosis and left ventricular hypertrophy induced in rats by prolonged inhibition of nitric oxide synthesis.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Enzyme Inhibitors; Hypertrophy, Left Ventricular; Imidazoles; Imidazolidines; Male; Nephrosclerosis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar | 1998 |
ET(A) receptor antagonist ameliorates nephrosclerosis and left ventricular hypertrophy induced in rat by prolonged inhibition of nitric oxide synthesis.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Drug Combinations; Endothelin Receptor Antagonists; Enzyme Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Imidazolidines; Male; Nephrosclerosis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Receptor, Endothelin A; Time Factors | 1998 |
Vascular endothelin-1 gene expression and synthesis and effect on renal type I collagen synthesis and nephroangiosclerosis during nitric oxide synthase inhibition in rats.
Topics: Animals; Blood Pressure; Collagen; Endothelin-1; Endothelins; Extracellular Matrix; Kidney; Kidney Glomerulus; Male; Microcirculation; Nephrosclerosis; NG-Nitroarginine Methyl Ester; Procollagen; Protein Precursors; Rats; Rats, Sprague-Dawley; Renal Circulation; RNA, Messenger; Systole; Transcription, Genetic | 1999 |
Mibefradil prevents L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Drug Antagonism; Enzyme Inhibitors; Hypertension; Mibefradil; Nephrosclerosis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Inbred SHR | 1999 |
Calcium antagonist inhibits glomerular cell apoptosis and injuries of L-NAME exacerbated nephrosclerosis in SHR.
Topics: Animals; Apoptosis; Calcium Channel Blockers; Cell Count; Dihydropyridines; Enzyme Inhibitors; Kidney Glomerulus; Nephrosclerosis; NG-Nitroarginine Methyl Ester; Nitrophenols; Organophosphorus Compounds; Proliferating Cell Nuclear Antigen; Rats; Rats, Inbred SHR | 2000 |
N- and L-type calcium channel antagonist improves glomerular dynamics, reverses severe nephrosclerosis, and inhibits apoptosis and proliferation in an l-NAME/SHR model.
Topics: Animals; Apoptosis; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Cell Division; Dihydropyridines; Enzyme Inhibitors; Hemodynamics; Kidney; Kidney Glomerulus; Male; Nephrosclerosis; NG-Nitroarginine Methyl Ester; Rats; Rats, Inbred SHR; Renal Circulation; Vascular Resistance | 2002 |